US7691805B2ExpiredUtilityA1
Antimicrobial compounds
Est. expiryNov 10, 2024(expired)· nominal 20-yr term from priority
A61P 31/10C07K 5/06095A61P 31/04A61P 31/16A61K 38/00A61P 31/20A61P 31/18A61P 31/14A61P 31/22Y02A50/30
64
PatentIndex Score
2
Cited by
21
References
6
Claims
Abstract
The invention relates to compositions comprising a compound based on the general formula (I) R 1 -Arg-R 2 —NH—CH(R 3 )—CH 2 —NH—R 4 (I) and a carrier, diluent or an excipient.
Claims
exact text as granted — not AI-modified1. A composition comprising
a) a compound selected from the group consisting of
and
b) a carrier, diluent or an excipient; wherein the composition is effective against a disease or a mixture of diseases caused by microorganisms selected from the group consisting of Staphylococci, Pneumococci, Streptococci, Listeria, Candida and Aspergillus.
2. The composition according to claim 1 , wherein the Staphylococci, Pneumococci, Streptococci or Listeria comprises a resistant or multiresistant bacteria.
3. The composition according to claim 1 , further comprising one or more therapeutic agents.
4. The composition according to claim 3 , wherein the therapeutic agents are selected from the group consisting of penicillins, cephalosporins, carbacephems, cephamycins, carbapenems, monobactams, aminoglycosides, glycopeptides, quinolones, tetracyclines, macrolides, fluoroquinolones, antiseptic agents, biguanides, docosanol, acetic acid, and hydrogen peroxide.
5. The composition according to claim 1 , wherein the composition is in the form selected from the group consisting of granules, powders, tablets, coated tablets, (micro) capsules, suppositories, syrups, emulsions, gels, ointments, suspensions, creams, aerosols, injectable solutions in ampule form, and drops.
6. A method of treating a mammal having a microbial infection or disease comprising administration of an effective amount of the composition according to claim 1 , wherein said microbial infection or disease is caused by microorganisms selected from the group consisting of Staphylococci, Pneumococci, Streptococci, Listeria, Candida and Aspergillus.Join the waitlist — get patent alerts
Track US7691805B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.